CMAC
Home
Journal Archive
Subscription
About
About
Author Guidelines
Editorial Board
Peer Review
Publishing Ethics
English
Русский
CMAC 2020; 22(1)
Type
Review
Original Article
Sections
Antimicrobial Resistance
Antimicrobials
Diseases and Pathogens
Personal Experience
The reasons why
Klebsiella pneumoniae
becomes a leading opportunistic pathogen
This review provides an analysis of causes why
Klebsiella pneumoniae
takes a leading place among opportunistic human bacteria. The …
Chebotar I.V.
,
Bocharova Yu.A.
,
Podoprigora I.V.
,
Shagin D.A.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(1):4-19
10.36488/cmac.2020.1.4-19
PDF
Cite
Doxycycline in the current clinical practice
This paper reviews clinical and pharmacological characteristics of doxycycline which is currently indicated for the treatment of some …
Zyryanov S.K.
,
Golub A.V.
,
Kozlov R.S.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(1):21-28
10.36488/cmac.2020.1.21-28
PDF
Cite
Use of chlorhexidine for the prophylaxis of nosocomial infections in ICU
This review summarizes published data on the use of chlorhexidine for the prevention of nosocomial infections in the intensive care …
Bagin V.A.
,
Rudnov V.A.
,
Astafieva M.N.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(1):30-38
10.36488/cmac.2020.1.30-38
PDF
Cite
Antimicrobial resistance of clinical
Streptococcus pyogenes
isolates in Russia: the results of multicenter epidemiological study «PEHASus 2014–2017»
Objective. To evaluate antimicrobial resistance patterns of clinical Streptococcus pyogenes isolates from different regions of Russia …
Ivanchik N.V.
,
Sukhorukova M.V.
,
Chagaryan А.N.
,
Dekhnich А.V.
,
Kozlov R.S.
,
Andreev V.A.
,
Bekker G.G.
,
Varganova A.N.
,
Gudkova L.V.
,
Ershova М.G.
,
Zholobova А.F.
,
Zubareva N.А.
,
Iskhakova L.М.
,
Kirillova G.Sh.
,
Krechikova О.I.
,
Lazareva А.V.
,
Morozova О.А.
,
Moskvitina Е.N.
,
Nagovitsyna S.G.
,
Petrova Т.А.
,
Rakhmanova O.A.
,
Salo E.A.
,
Chernyavskaya Yu.L.
,
Yarantseva N.Z.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(1):40-45
10.36488/cmac.2020.1.40-45
PDF
Cite
Resistance of carbapenemase-producing
Klebsiella pneumoniae
isolated from patients with orthopedic infection
Objective. To evaluate the resistance rate and production of carbapenemases in Klebsiella pneumoniae with phenotypic resistance to …
Bozhkova S.A.
,
Gordina E.M.
,
Schneider O.V.
,
Rukina A.N.
,
Shabanova V.V.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(1):47-52
10.36488/cmac.2020.1.47-52
PDF
Cite
Experience with the AMRcloud online platform for antimicrobial resistance surveillance in zoonotic bacteria
Objective. To develop an approach to comprehensive analysis and presentation of data on antibiotic resistance of zoonotic bacteria to …
Makarov D.A.
,
Karabanov S.Yu.
,
Krylova E.V.
,
Pobolelova Yu.I.
,
Ivanova O.E.
,
Gergel M.A.
,
Kulikovskij A.V.
,
Sukhoedova A.V.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(1):53-59
10.36488/cmac.2020.1.53-59
PDF
Cite
Therapeutic drug monitoring of vancomycin in patients with infectious complications in traumatology and orthopedics
Objective. The purpose of this study was to study the frequency of achievement of target values of vancomycin residual concentration …
Borisov A.M.
,
Galankin T.L.
,
Bozhkova S.A.
,
Verbitskaya E.V.
,
Kasimova A.R.
,
Koroleva E.M.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(1):60-66
10.36488/cmac.2020.1.60-66
PDF
Cite
The effect of the surgical hemostatic product «Hemoblock»TM on
in vitro
bacterial colonization
Objective. To evaluate effect of «Haemoblock»TM preparation on in vitro bacterial colonization. Materials and Methods. Activity of …
Kuznetsova M.V.
,
Parshakov A.A.
,
Kuznetsova M.P.
,
Afanasievskaya E.V.
,
Gavrilov V.A.
,
Samartsev V.A.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(1):67-70
10.36488/cmac.2020.1.67-70
PDF
Cite
The efficacy and safety of direct-acting antiviral agents in patients with chronic HCV infection and UGT1A1*28 polymorphism
Objective. To determine the efficacy and safety of direct-acting antiviral agents (DAA) in patients with chronic HCV infection and …
Lukashyk S.P.
,
Karpov I.A.
,
Siniauskaya M.G.
,
Danilenko N.G.
,
Anisko L.A.
,
Davydenko O.G.
,
Krasko O.V.
Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(1):71-80
10.36488/cmac.2020.1.71-80
PDF
Cite
Cite
×
